T cell tolerance to the skin: a central role for central tolerance

Gallegos AM, Bevan MJ (2004) Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 200:1039–1049 von Boehmer H, Kisielow P (2006) Negative selection of the T cell repertoire: where and when does it occur? Immunol Rev 209:284–289 Mathis D, Benoist C (2004) Back to central tolerance. Immunity 20:509–516 Kyewski B, Klein L (2006) A central role for central tolerance. Annu Rev Immunol 24:571–606 Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH (2006) Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7:1092–1100 Redmond WL, Sherman LA (2005) Peripheral tolerance of CD8 T lymphocytes. Immunity 22:275–284 Heath WR, Kurts C, Miller JF, Carbone FR (1998) Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 187:1549–1553 Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153–162 Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21:305–334 Redmond WL, Marincek BC, Sherman LA (2005) Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo. J Immunol 174:2046–2053 Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175:165–170 Skapenko A, Lipsky PE, Schulze-Koops H (2006) T cell activation as starter and motor of rheumatic inflammation. Curr Top Microbiol Immunol 305:195–211 Delgado S, Sheremata WA (2006) The role of CD4+ T-cells in the development of MS. Neurol Res 28:245–249 McDole J, Johnson AJ, Pirko I (2006) The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol Res 28:256–261 Mintern JD, Sutherland RM, Lew AM, Shortman K, Carbone FR, Heath WR (2002) Constitutive, but not inflammatory, cross-presentation is disabled in the pancreas of young mice. Eur J Immunol 32:1044–1051 Gallegos AM, Bevan MJ (2006) Central tolerance: good but imperfect. Immunol Rev 209:290–296 Oostingh GJ, Sitaru C, Kromminga A, Dormann D, Zillikens D (2002) Autoreactive T cell responses in pemphigus and pemphigoid. Autoimmun Rev 1:267–272 Shibaki A, Sato A, Vogel JC, Miyagawa F, Katz SI (2004) Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol 123:109–115 McGargill MA, Derbinski JM, Hogquist KA (2000) Receptor editing in developing T cells. Nat Immunol 1:336–341 Azukizawa H, Kosaka H, Sano S, Heath WR, Takahashi I, Gao XH, Sumikawa Y, Okabe M, Yoshikawa K, Itami S (2003) Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 33:1879–1888 Zheng X, Yin L, Liu Y, Zheng P (2004) Expression of tissue-specific autoantigens in the hematopoietic cells leads to activation-induced cell death of autoreactive T cells in the secondary lymphoid organs. Eur J Immunol 34:3126–3134 Lees JR, Charbonneau B, Swanson AK, Jensen R, Zhang J, Matusik R, Ratliff TL (2006) Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology 117:248–261 Kurts C, Heath WR, Kosaka H, Miller JF, Carbone FR (1998) The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med 188:415–420 Vezys V, Olson S, Lefrancois L (2000) Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 12:505–514 Ohlen C, Kalos M, Cheng LE, Shur AC, Hong DJ, Carson BD, Kokot NC, Lerner CG, Sather BD, Huseby ES, Greenberg PD (2002) CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med 195:1407–1418 Perchellet A, Stromnes I, Pang JM, Goverman J (2004) CD8+ T cells maintain tolerance to myelin basic protein by ‘epitope theft’. Nat Immunol 5:606–614 McPherson SW, Yang J, Chan CC, Dou C, Gregerson DS (2003) Resting CD8 T cells recognize beta-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated. Immunology 110:386–396 McGargill MA, Mayerova D, Stefanski HE, Koehn B, Parke EA, Jameson SC, Panoskaltsis-Mortari A, Hogquist KA (2002) A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J Immunol 169:2141–2147 Mayerova D, Parke EA, Bursch LS, Odumade OA, Hogquist KA (2004) Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21:391–400 Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351–358 Himmelweit F (1956-1960) Collected Papers of Paul Ehrlich. (Pergamon, London) Mayerova D, Wang L, Bursch LS, Hogquist KA (2006) Conditioning of Langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo. J Immunol 176:4658–4665 Garbelli S, Mantovani S, Palermo B, Giachino C (2005) Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity? Pigment Cell Res 18:234–242 Schuler P, Contassot E, Irla M, Preynat-Seauve O, Beermann F, Donda A, French LE, Huard B (2007) Direct presentation of the self-antigen tyrosinase in peripheral lymph nodes induces cytotoxic CD8+ T cells. (in press) Douillard P, Stoitzner P, Tripp CH, Clair-Moninot V, Ait-Yahia S, McLellan AD, Eggert A, Romani N, Saeland S (2005) Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol 125:983–994 Ohta T, Iwakawa M, Oohira C, Noda S, Minfu Y, Goto M, Tanaka H, Harada Y, Imai T (2004) Fractionated irradiation augments inter-strain variation of skin reactions among three strains of mice. J Radiat Res (Tokyo) 45:515–519 Carson KF, Wen DR, Li PX, Lana AM, Bailly C, Morton DL, Cochran AJ (1996) Nodal nevi and cutaneous melanomas. Am J Surg Pathol 20:834–840 Gonzalez-Campora R, Galera-Davidson H, Vazquez-Ramirez FJ, Diaz-Cano S (1994) Blue nevus: classical types and new related entities. A differential diagnostic review. Pathol Res Pract 190:627–635 Mancini L, Gubinelli M, Fortunato C, Carella R (1992) Blue nevus of the lymph node capsule. Report of a case. Pathologica 84:547–550 Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH (2006) Immunity to melanoma antigens: from self-tolerance to immunotherapy. Adv Immunol 90:243–295 Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17–27 Steitz J, Wenzel J, Gaffal E, Tuting T (2004) Initiation and regulation of CD8+ T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol 83:797–803 Dooley J, Erickson M, Gillard GO, Farr AG (2006) Cervical thymus in the mouse. J Immunol 176:6484–6490 Terszowski G, Muller SM, Bleul CC, Blum C, Schirmbeck R, Reimann J, Pasquier LD, Amagai T, Boehm T, Rodewald HR (2006) Evidence for a functional second thymus in mice. Science 312:284–287 Kyewski B, Derbinski J (2004) Self-representation in the thymus: an extended view. Nat Rev Immunol 4:688–698 Grimes PE (2005) New insights and new therapies in vitiligo. JAMA 293:730–735 Matzinger P (2002) An innate sense of danger. Ann N Y Acad Sci 961:341–342 Olson JK, Croxford JL, Miller SD (2001) Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 14:227–250 Punt JA, Osborne BA, Takahama Y, Sharrow SO, Singer A (1994) Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med 179:709–713 Jimenez M, Tsukamoto K, Hearing VJ (1991) Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266:1147–1156